- 2025
-
Press releases - 23.10.2025
International influence: Inserm highlights its scientific collaborations with the United Kingdom
Inserm continues to highlight its international collaborations in health research. In 2025, the Institute will focus on its fruitful collaboration with its British partners. The programme includes a day of scientific and institutional exchanges to be held on October 27, 2025, at the French Residence in London, attended by Prof. Didier Samuel, President and CEO of Inserm, and numerous partner institutions.
-
Press releases - 20.10.2025
Subretinal implant partially restores vision in AMD patients
Age-related macular degeneration (AMD) causes progressive vision loss in many elderly people, and no treatment is available for the so-called atrophic form of the disease. A neurostimulation system called Prima, including a subretinal implant, could change all that.
-
Press releases - 07.10.2025
Level of processing of plant products: impact on cardiovascular health
Consumption of plant-based products is associated with better cardiovascular health, provided they are of good nutritional quality and not or minimally processed. This is the finding of a research team from INRAE, Inserm, Sorbonne Paris Nord University and Cnam, based on analysis of health data from a cohort of 63,835 adults.
-
What's on? - 06.10.2025
Nobel Prize in Medicine: Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi rewarded for discovery of regulatory T cells
The Nobel Prize for Medicine was awarded to American researchers Mary E. Brunkow and Fred Ramsdell, and Japanese researcher Shimon Sakaguchi, for their discoveries in peripheral immune tolerance. Inserm looks back at the importance of this work, particularly for research into cancer and autoimmune diseases.
-
Press releases - 24.09.2025
Astrocytes, the unexpected conductors of brain networks
A collaborative French-Swiss study reveals a previously unknown role for astrocytes in the brain’s information processing.
-
Press releases - 19.09.2025
Consumption of food additives during pregnancy: effects on offspring microbiota increase susceptibility to inflammatory diseases
A study conducted in mice by scientists from the Institut Pasteur and Inserm reveals that maternal consumption of dietary emulsifiers can have a negative impact on the gut microbiota of their offspring.
-
Press releases - 17.09.2025
Massaging the skin to vaccinate: a possible alternative to injections?
What if vaccination could be administered by simple skin application rather than injection? A team of researchers from Inserm, Institut Curie, and King’s College London investigated the impact of external mechanical constraints (skin stretching, friction, etc.) on skin impermeability in animals and humans.
-
Press releases - 16.09.2025
Economic inequalities could contribute to France’s recent rise in neonatal mortality
With neonatal mortality on the increase in France, a new study by Inserm, Paris Cité University, Inrae, Paris Nord University and APHP shows that it could be linked to socioeconomic inequalities. Using their social deprivation index adjusted for the perinatal period, the researchers observed that the risk of neonatal death is higher for mothers living in deprived municipalities.
-
Press releases - 05.09.2025
A new antibody-drug conjugate shows promising results in metastatic breast cancer
A new study, published in Nature Medicine, highlights the efficacy of patritumab deruxtecan (HER3-DXd), an antibody HER3-directed-drug conjugate (ADC), in patients with hormone receptor-positive metastatic breast cancer who had already received multiple treatments, including hormone therapy, chemotherapy, and targeted therapies.
-
Press releases - 24.07.2025
A human protein inherited from bacteria reveals an overlooked aspect of human immunity
In recent years, scientists have been exploring unexpected links between human proteins involved in the body’s defense mechanisms and certain bacterial immune proteins. Focusing on conserved immune domains originating from bacteria, termed “ancestral immune”, a team of researchers from Institut Curie, Institut Pasteur, and Inserm identified a novel human immune protein, SIRal.